Clinical efficacy of complement C5a inhibition by IFX‐1 in hidradenitis suppurativa: an open‐label single‐arm trial in patients not eligible for adalimumab
Giamarellos‐Bourboulis, E.J., Argyropoulou, M., Kanni, T., Spyridopoulos, T., Otto, I., Zenker, O., Guo, R., Riedemann, N.C.
Published in British journal of dermatology (1951) (01.07.2020)
Published in British journal of dermatology (1951) (01.07.2020)
Get full text
Journal Article